Prof. George Armah; Ph.D (Ghana)

Scientific advisory experts   /   George Armah


Prof. George Armah; Ph.D. (Ghana)

Professor Armah is a senior research fellow and an associate professor in the Department of Electron Microscopy and Histopathology at the Noguchi Memorial Institute for Medical Research, University of Ghana and the chairman of the National Immunization Technical Advisory Group (NITAG) of Ghana. He is the head of the West African Regional Rotavirus Reference Laboratory, which provides technical support, resources and training for rotavirus surveillance in Africa. George has spent nearly two decades working on rotavirus in Africa and is an active member of the African Rotavirus Network. His research focuses on enteric diseases and specifically, the epidemiology of rotavirus and norovirus in Africa and their genetic and antigenic characterizations. Professor Armah is also a senior clinical trials program lecturer at the University of Ghana School of Public Health. Professor Armah is a member of Vaccines for Africa, a group of African volcanologists, scientists and public health advocates working to accelerate the introduction of lifesaving childhood vaccines within the region and to promote equity in access to these vaccines. In 2013 he was honored by the International Double stranded RNA Virus conference in Puerto Rico for his outstanding contribution to the field of Rotavirus virology and for Rotavirus Vaccine introduction in Africa. Professor Armah holds a PhD in Biophysical Chemistry and Immunology from Osaka University, Japan and an MSc in Physics from the University of Ghana, Legon. His interest is in enteric viral diarrhea disease in African children and his research focus has been centered on burden and etiology of diarrhea disease, epidemiology of rotaviruses and their evolution in the African setting. George is also interested in understanding the observed low efficacy of rotavirus vaccines in developing countries. He has been involved in several clinical trials on immunogenicity, safety and efficacy trials of rotavirus vaccines in Africa. His work on the multi country clinical field trial on the safety and efficacy on the RotaTeq vaccine in Africa was critical in the informed decision to recommend the introduction of rotavirus vaccines in the developing countries. He continues to be involved in efforts to monitor the impact and safety of rotavirus vaccines as they are introduced in African countries. In recognition for these efforts, he was declared a “Vaccine Hero” in 2011 by the Bill and Melinda Gates Foundation. He is a foundation member of the International Rotavirus Organization of Technical Advisers (ROTA) council. Professor Armah has authored or co-authored over 30 peer-reviewed publications and textbook chapters.